Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

A research team has introduced a novel cancer immunotherapy strategy. This approach involves attaching "fake targets" to ...

Nanomedicine uses ultra-small particles to deliver drugs directly to the tissues and cells that need them, improving ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...